93 related articles for article (PubMed ID: 30116029)
1. Association of anxiety with subcortical amyloidosis in cognitively normal older adults.
Hanseeuw BJ; Jonas V; Jackson J; Betensky RA; Rentz DM; Johnson KA; Sperling RA; Donovan NJ
Mol Psychiatry; 2020 Oct; 25(10):2599-2607. PubMed ID: 30116029
[TBL] [Abstract][Full Text] [Related]
2. Association of Higher Cortical Amyloid Burden With Loneliness in Cognitively Normal Older Adults.
Donovan NJ; Okereke OI; Vannini P; Amariglio RE; Rentz DM; Marshall GA; Johnson KA; Sperling RA
JAMA Psychiatry; 2016 Dec; 73(12):1230-1237. PubMed ID: 27806159
[TBL] [Abstract][Full Text] [Related]
3. Association of Cortical and Subcortical β-Amyloid With Standardized Measures of Depressive and Anxiety Symptoms in Adults Without Dementia.
Krell-Roesch J; Syrjanen JA; Rakusa M; Vemuri P; Machulda MM; Kremers WK; Mielke MM; Lowe VJ; Jack CR; Knopman DS; Stokin GB; Petersen RC; Vassilaki M; Geda YE
J Neuropsychiatry Clin Neurosci; 2021; 33(1):64-71. PubMed ID: 33086924
[TBL] [Abstract][Full Text] [Related]
4. Patterns of Cortical and Subcortical Amyloid Burden across Stages of Preclinical Alzheimer's Disease.
Edmonds EC; Bangen KJ; Delano-Wood L; Nation DA; Furst AJ; Salmon DP; Bondi MW;
J Int Neuropsychol Soc; 2016 Nov; 22(10):978-990. PubMed ID: 27903335
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal Association of Amyloid Beta and Anxious-Depressive Symptoms in Cognitively Normal Older Adults.
Donovan NJ; Locascio JJ; Marshall GA; Gatchel J; Hanseeuw BJ; Rentz DM; Johnson KA; Sperling RA;
Am J Psychiatry; 2018 Jun; 175(6):530-537. PubMed ID: 29325447
[TBL] [Abstract][Full Text] [Related]
6. PET staging of amyloidosis using striatum.
Hanseeuw BJ; Betensky RA; Mormino EC; Schultz AP; Sepulcre J; Becker JA; Jacobs HIL; Buckley RF; LaPoint MR; Vannini P; Donovan NJ; Chhatwal JP; Marshall GA; Papp KV; Amariglio RE; Rentz DM; Sperling RA; Johnson KA; ;
Alzheimers Dement; 2018 Oct; 14(10):1281-1292. PubMed ID: 29792874
[TBL] [Abstract][Full Text] [Related]
7. High amyloid-β deposition related to depressive symptoms in older individuals with normal cognition: a pilot study.
Yasuno F; Kazui H; Morita N; Kajimoto K; Ihara M; Taguchi A; Yamamoto A; Matsuoka K; Kosaka J; Kudo T; Iida H; Kishimoto T; Nagatsuka K
Int J Geriatr Psychiatry; 2016 Aug; 31(8):920-8. PubMed ID: 26766490
[TBL] [Abstract][Full Text] [Related]
8. Age-specific and sex-specific prevalence of cerebral β-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50-95 years: a cross-sectional study.
Jack CR; Wiste HJ; Weigand SD; Therneau TM; Knopman DS; Lowe V; Vemuri P; Mielke MM; Roberts RO; Machulda MM; Senjem ML; Gunter JL; Rocca WA; Petersen RC
Lancet Neurol; 2017 Jun; 16(6):435-444. PubMed ID: 28456479
[TBL] [Abstract][Full Text] [Related]
9. Association of brain amyloidosis with the incidence and frequency of neuropsychiatric symptoms in ADNI: a multisite observational cohort study.
Goukasian N; Hwang KS; Romero T; Grotts J; Do TM; Groh JR; Bateman DR; Apostolova LG
BMJ Open; 2019 Dec; 9(12):e031947. PubMed ID: 31857304
[TBL] [Abstract][Full Text] [Related]
10. Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease.
Quiroz YT; Sperling RA; Norton DJ; Baena A; Arboleda-Velasquez JF; Cosio D; Schultz A; Lapoint M; Guzman-Velez E; Miller JB; Kim LA; Chen K; Tariot PN; Lopera F; Reiman EM; Johnson KA
JAMA Neurol; 2018 May; 75(5):548-556. PubMed ID: 29435558
[TBL] [Abstract][Full Text] [Related]
11. Association of Apolipoprotein E ε4 With Medial Temporal Tau Independent of Amyloid-β.
Therriault J; Benedet AL; Pascoal TA; Mathotaarachchi S; Chamoun M; Savard M; Thomas E; Kang MS; Lussier F; Tissot C; Parsons M; Qureshi MNI; Vitali P; Massarweh G; Soucy JP; Rej S; Saha-Chaudhuri P; Gauthier S; Rosa-Neto P
JAMA Neurol; 2020 Apr; 77(4):470-479. PubMed ID: 31860000
[TBL] [Abstract][Full Text] [Related]
12. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.
Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H;
Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152
[TBL] [Abstract][Full Text] [Related]
13. Cortical β-amyloid burden, neuropsychiatric symptoms, and cognitive status: the Mayo Clinic Study of Aging.
Krell-Roesch J; Vassilaki M; Mielke MM; Kremers WK; Lowe VJ; Vemuri P; Machulda MM; Christianson TJ; Syrjanen JA; Stokin GB; Butler LM; Traber M; Jack CR; Knopman DS; Roberts RO; Petersen RC; Geda YE
Transl Psychiatry; 2019 Mar; 9(1):123. PubMed ID: 30923322
[TBL] [Abstract][Full Text] [Related]
14. Depressive and anxiety symptoms and cortical amyloid deposition among cognitively normal elderly persons: the Mayo Clinic Study of Aging.
Krell-Roesch J; Lowe VJ; Neureiter J; Pink A; Roberts RO; Mielke MM; Vemuri P; Stokin GB; Christianson TJ; Jack CR; Knopman DS; Boeve BF; Kremers WK; Petersen RC; Geda YE
Int Psychogeriatr; 2018 Feb; 30(2):245-251. PubMed ID: 29198244
[TBL] [Abstract][Full Text] [Related]
15. Dynamic relationships between age, amyloid-β deposition, and glucose metabolism link to the regional vulnerability to Alzheimer's disease.
Oh H; Madison C; Baker S; Rabinovici G; Jagust W
Brain; 2016 Aug; 139(Pt 8):2275-89. PubMed ID: 27190008
[TBL] [Abstract][Full Text] [Related]
16. Cortical β-amyloid burden, gray matter, and memory in adults at varying APOE ε4 risk for Alzheimer's disease.
Mecca AP; Barcelos NM; Wang S; Brück A; Nabulsi N; Planeta-Wilson B; Nadelmann J; Benincasa AL; Ropchan J; Huang Y; Gelernter J; Van Ness PH; Carson RE; van Dyck CH
Neurobiol Aging; 2018 Jan; 61():207-214. PubMed ID: 29111487
[TBL] [Abstract][Full Text] [Related]
17. Subcortical amyloid load is associated with shape and volume in cognitively normal individuals.
Rahayel S; Bocti C; Sévigny Dupont P; Joannette M; Lavallée MM; Nikelski J; Chertkow H; Joubert S
Hum Brain Mapp; 2019 Sep; 40(13):3951-3965. PubMed ID: 31148327
[TBL] [Abstract][Full Text] [Related]
18. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.
Engler H; Forsberg A; Almkvist O; Blomquist G; Larsson E; Savitcheva I; Wall A; Ringheim A; Långström B; Nordberg A
Brain; 2006 Nov; 129(Pt 11):2856-66. PubMed ID: 16854944
[TBL] [Abstract][Full Text] [Related]
19. Low amyloid-β deposition correlates with high education in cognitively normal older adults: a pilot study.
Yasuno F; Kazui H; Morita N; Kajimoto K; Ihara M; Taguchi A; Yamamoto A; Matsuoka K; Kosaka J; Kudo T; Iida H; Kishimoto T
Int J Geriatr Psychiatry; 2015 Sep; 30(9):919-26. PubMed ID: 25425062
[TBL] [Abstract][Full Text] [Related]
20. Social Engagement and Amyloid-β-Related Cognitive Decline in Cognitively Normal Older Adults.
Biddle KD; d'Oleire Uquillas F; Jacobs HIL; Zide B; Kirn DR; Rentz DM; Johnson KA; Sperling RA; Donovan NJ
Am J Geriatr Psychiatry; 2019 Nov; 27(11):1247-1256. PubMed ID: 31248770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
